Fig. 1From: Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)Local control rate (A), overall survival (B), disease free survival (C), local-regional recurrence free survival (D), distant metastasis free survival (E) of the enrolled patients in ESO-Shanghai 8 study (RT group) and this study (CRT group)Back to article page